UniPharma Co., Ltd.
6621
Rank in Stocks
#27828
UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution... UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution of pharmaceuticals, medical apparatus, and diagnostic kits. Its diagnostic portfolio encompasses various medical disciplines, including oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company's offerings feature products such as Adept reduction solution, anesthetic injections (including bain, esmolol HCI, and naloxone), the Elisa DR-70 test for in-vitro tumor detection, and Fomeject antidote injections. Furthermore, UniPharma extends its services to include drug development, research and development, clinical studies, and marketing. Its client base includes major medical centers, regional hospitals, and local clinics. Founded in 1998, UniPharma is headquartered in Taipei, Taiwan.
Share Price
$0.37343462
Last synced: 2026-11-10
Market Cap
$13.26M
Change (1 day)
0.41%
Change (1 year)
-5.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade UniPharma Co., Ltd. (6621)
Category
Healthcare
Operating Margin for UniPharma Co., Ltd. (6621)
Operating Margin as of November 2026 TTM: -54.60%
According to UniPharma Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -54.60%. At the end of 2025 the company had an operating margin of -49.89%.
Operating Margin history for UniPharma Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -54.60% | 9.44% |
| 2025 | -49.89% | 51.27% |
| 2024 | -32.98% | 24.69% |
| 2023 | -26.45% | 62.27% |
| 2022 | -16.30% | -57.30% |
| 2021 | -38.17% | 156.69% |
| 2020 | -14.87% | -17.48% |
| 2019 | -18.02% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.36% |
DE
|
|
| 19.68% | -100.36% |
DE
|
|
| 13.26% | -100.24% |
JP
|
|
| 17.08% | -100.31% |
CH
|
|
| 14.92% | -100.27% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about UniPharma Co., Ltd.'s operating margin
What is UniPharma Co., Ltd.'s operating margin?
UniPharma Co., Ltd.'s operating margin is -54.60%, as of Nov 2026.
What was UniPharma Co., Ltd.'s operating margin in 2025?
In 2025, UniPharma Co., Ltd.'s operating margin was -49.89%, compared with -32.98% in 2024.
How has UniPharma Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, UniPharma Co., Ltd.'s operating margin was highest in 2020 (-14.87%) and lowest in 2025 (-49.89%).
How does UniPharma Co., Ltd.'s operating margin compare with similar companies?
UniPharma Co., Ltd.'s operating margin (-54.60%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.